Professor Thomas McGlashan was present at the inauguration of the IEPA Advisory Board in June, 1997, at Stratford-upon-Avon (and traveled to that meeting with Richard Wyatt). He has been on the Board and active in the IEPA ever since. He has attended all three international meetings, and was responsible for the scientific program of the second meeting in New York. He is an active clinical researcher of early psychosis as co-PI (with Per Vaglum) of the TIPS Project in Norway and Denmark, and as PI of the PRIME North America project. The former seeks to alter the duration of untreated psychosis in schizophrenia and measure its effects on the course of illness, and the latter seeks to determine if atypical antispychotic treatment in the prodromal phase of illness has secondary and tertiary preventive efficacy. He is convinced that the early phases of psychosis hold crucial keys to understanding the nature of schizophrenia and its treatment. He has been and remains convinced that empirical research in early psychosis is the only guarantee of the strength and long-term viability of the IEPA, and he is proud of being regarded as the "usually skeptical" member of the organization.

Tom has been a Professor in the Yale University School of Medicine since 1990. He is now happily engaged in full time clinical research after a decade as CEO of Yale Psychiatric Institute. His learning has included the study of medicine at the University of Pennsylvania, of psychiatry at Harvard, of psychopharmacology research in the U.S. Public Health Service, of schizophrenia's phenomenology at NIH with Will Carpenter, and of schizophrenia's soul at Chestnut Lodge Hospital. His is 61 years old at this writing, happily married for 38 years to Patricia Gwiazdowski. He recently saw his younger daughter get married and he looks forward to skiing with his older daughter at Vail during the week before the International Congress on Schizophrenia Research in March, 2003. It will be his 54th year of skiing. Anyone interested in joining him?